Patritumab deruxtecan

(Synonyms: HER3-DXd; U3-1402)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.08%
  • CAS. Nr.: 2227102-46-5
  • Molecular Weight:155238 (average)
  • Speicherung:

    -80°C, protect from light

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Patritumab deruxtecan

More
100 mg
Angebot einholen Auf Lager
Please select quantity
Price: USD 0.00